ArticleBone marrow transplantation2006
Therapy for severe refractory acute graft-versus-host disease with basiliximab, a selective interleukin-2 receptor antagonist.
V A M Funke et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papertrialcites it